disorder may occasionally present to the dermatologist with intense pruritus without clinically evident jaundice", The pattern of cutaneous abnormality seen in this child is highly unusual, and does not fit into any recognized pattern of keratoderma; nor have such changes previously been reported in association with arteriohepatic dysplasia. Whether the changes should be regarded as an unusual reaction pattern to chronic cholestatic pruritus, or as a primary keratoderma remains unclear. Thyrotoxicosis due to pituitary hypersecretion of thyrotrophin <TSH) is uncommon'. In some reports there has been an association with hyperprolactinaemia and/or amenorrhoea and galactorrhoear". We report the case of a young female presenting with amenorrhoea and galactorrhoea who was subsequently found to have thyrotoxicosis and where the primary cause of all of the abnormalities was a TSH-secreting pituitary macro-adenoma. 
A pituitary thyrotrophinoma causing thyrotoxicosis and amenorrhoeal galactorrhoea: studies of a-subunit in the tumour and in blood

Special investigations
Levels of hormones in serum were measured using standard radioimmunoassays. Levels of a-subunit in blood were estimated as previously described", Sections for immunocytochemical study were stained by a standard peroxidaseantiperoxidase (PAP) method using polyclonal antibodies. Immunostaining for a-subunit was carried out using primary antibodies at a concentration of 1 : 1 000.
Case report
An 18-year-oldfemale presented to a gynaecology department with a history of menstrual irregularity progressing to amenorrhoea with galactorrhoea. Thyroid function tests were checked and the serum total T 4 concentration was 200 nmol/I (normal up to 160). There were no signs of ophthalmopathy and thyroid antibodies were negative. No treatment was given. Five months later the thyroid function tests were more abnormal, with total T 4 231, free T 4 index 177 (normal up to 160). Treatment was commenced with carbimazole, 30 mg per day. Galactorrhoea worsened and the serum prolactin was found to be 3100 mUll (normal less than 600); at this time the free T 4 index was 175. The patient was referred to the endocrine clinic, where the serum prolactin was found to be 3962 mUll. The skull X-ray had been reported originally to be normal but a repeat film showed elevation and displacement of the posterior clinoid process. A full pituitary endocrine assessment <Table 1) showed a defective growth hormone response and a high basal level ofTSH with an exaggerated response to thyrotrophin releasing hormone (TRH) stimulation despite normal thyroid hormone levels. The same blood samples were analysed for a-subunit and the basal level was elevated <Table 2), with a marked further increase after TRH stimulation.
Two months after the pituitary studies the patient presented as an emergency with headache, vomiting, blurred vision and a field defect. High definition CT scanning revealed a 25x 15 mm pituitary adenoma with suprasellar extension. The adenoma was completely removed via a frontal craniotomy, the pituitary gland and stalk being left intact.
Histology of the tumour showed a mixed sinusoidal adenoma with many acidophil cells. Immunocytochemistry was positive for TSH but negative for prolactin and for other anterior pituitary hormones; there was also very heavy immunostaining for a-subunit. Electron microscopy (Figure 1) showed the cells to have sparse, very fine granules, mainly peripherally placed. Postoperatively the patient became euthyroid and has remained so for 2 years without specific treatment. Her galactorrhoea has ceased but she remains growth hormone adrenocorticotrophic hormone and oestrogen deficient: during a pituitary reassessment three months postoperatively using glucagon stimulation, serum cortisol levels failed to rise above 80 nmol/1. The response of the pituitary to gonadotrophin releasing hormone (GnRH 100 JLg intravenously) showed that gonadotrophin secretion had been preserved (follicle-stimulating hormone levels rising from 3.7 to 5.3 UIl, luteinizing hormone from 3.7 to 9.0 UIl) but the plasma oestradiol was less than 125 pmol/l,
Discussion
Thyrotoxicosis due to a thyrotrophinoma may be diagnosed only where there is: (a) biochemical evidence of thyrotoxicosis; (b) absence of ophthalmology and of thyroidstimulating antibodies; (c) elevated TSH levels despite thyrotoxicosis; (d) the presence of a pituitary tumour with histological evidence of thyrotrophs; (e) resolution of the thyrotoxicosis following removal of the tumour'". In our patient, TSH levels were not estimated until after treatment for thyrotoxicosis had been started; nevertheless, at a time when thyroid function tests were normal the basal TSH level was elevated and there was a further rise in response to TRH stimulation. Such a pattern of TSH secretion would be very unusual in a patient with primary thyrotoxicosis but is compatible with some reports on the behaviour of thyrotrophinornas". Our patient also satisfies criteria (a),(b), (d) and (e) above; in particular the pattern of granulation seen with electron-microscopy in this case is typical of thyrotrophs and would not be likely to occur in lactotrophs".
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Several groups have demonstrated the value of measuring a-subunit levels in these patients, since thyrotrophinomas seem to secrete this material in greater amounts than !3_TSH1,3,5.S. The basal level of a-subunit in the patient's serum was elevated and rose further after TRH injection, suggesting that a-subunit production could respond to hypothalamic releasing factors. This pattern differs from that described by a number of other authors 1 ,9,10. The association of a thyrotrophinoma with hyperprolactinaemia and amenorrhoea is well documented. In most cases the level of serum prolactin is only mildly elevated 2 -5, although in our case there was quite considerable hyperprolactinaemia. However, there was no histological evidence of lactotrophs in the tumour and it is possible that the hyperprolactinaemia resulted from interference with pituitary stalk function. considered to be a benign 'syncytial endometritis'. It is now recognized that PSST is a potentially lethal disease and that it is characterized by cytotrophoblastic cells with less syncytiotrophoblast than is found in choriocarcinoma", With further experience 42 cases of PSTI have been reported, of which four have been observed following a hydatidiform mole". We describe the case of a young woman with a malignant drug resistant PSTI following a hydatidiform mole. In this instance, management was guided by the use of antibody imaging with a monoclonal antibody to human chorionic gonadotrophin meG).
Antibody
Case report
A 19-year-oldwoman, of Pakistani origin, had a normal birth in June 1984, and presented elsewhere in October 1985 following two months amenorrhoea. At this time a pregnancy test was positive, and uterine ultrasound examination was consistent with a hydatidiform mole. Suction evacuation and subsequent histology revealed a complete hydatidiform mole.
